Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CDKN2 mutations in melanoma

N C Dracopoli1, J W Fountain

  • 1Sequana Therapeutics Inc., La Jolla, California 92037, USA.

Cancer Surveys
|January 1, 1996
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PTEN inactivation is rare in melanoma tumours but occurs frequently in melanoma cell lines.

Melanoma research·2002
Same author

Progress in high throughput SNP genotyping methods.

The pharmacogenomics journal·2002
Same author

Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis.

American journal of human genetics·2000
Same author

Functional localization of a melanoma tumor suppressor gene to a small (< or = 2 Mb) region on 11q23.

Oncogene·1999
Same author

In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.

Genes, chromosomes & cancer·1998